Professional Marketing briefs

Share this article:
GfK Healthcare launched its Managed Markets Practice Area, a new business unit focused on meeting the marketing research needs of pharma clients navigating the managed markets landscape. Custom research services include conducting ad-hoc qualitative projects, mock P&T committee meetings, advisory boards, convention focus groups and executing quantitative projects of any scale or complexity.

Interactive exhibit agency Blue Telescope, was awarded the Silver Summit Creative Award for the design of the “Pfizer Neuroscience Race,” showcased at the APA annual meeting. Blue Telescope created the “Pfizer Neuroscience Race” to serve as the centerpiece of the Pfizer APA booth.

Oscient Pharmaceuticals will layoff 180 from its staff, including its 150-person sales force and approximately 30 other sales and marketing positions, as part a restructuring effort. The layoffs will start in August. The Waltham, MA-based company will also discontinue sales force promotion on two products: Antara (fenofibrate), a cardiovascular drug, and Factive (gemifloxacin mesylate), an antibiotic. The products will continue to be available to physicians and patients.
Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Features

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Features

Read the complete September 2014 Digital Edition

Read the complete September 2014 Digital Edition

Click the above link to access the complete Digital Edition of the August 2014 issue of MM&M, with all text, charts and pictures.

Medical marketing needs mainstream Mad Men

Medical marketing needs mainstream Mad Men

Agencies must generate emotional resonance with the target audience, not unlike Apple, Pepsi or Nike

Are discounts cutting out co-pays?

GSK's decision to cut Advair's price spurred some PBMs to put it back on formulary. Will drugmaker discounts diminish the need for loyalty programs? How can these programs stay relevant beyond giving co-pay assistance?